Tryn Stimart's most recent trade in AbCellera Biologics Inc was a trade of 539,265 Share option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 539,265 | 4,646,012 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 832,033 | 4,106,747 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Stimart Tryn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 616,333 | 3,274,714 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 346,901 | 2,658,381 | - | - | Share Options (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 270,680 | 2,311,480 | - | - | Share Option (right to buy) |